Standards for Cancer Registries, Volume II: Data Standards and Data Dictionary, Eighth Edition. COC Collect. COC Transmit
|
|
|
- Eustace Thornton
- 6 years ago
- Views:
Transcription
1 10 Record Type R R NAACCR 20 Patient ID Number R R R Reporting Registry 30 Registry Type NAACCR 35 FIN Coding System S NAACCR 37 Reserved Registry ID S R R NAACCR 50 NAACCR Record Version R R NAACCR 60 Tumor Record Number S NAACCR Revised 70 Addr at DX--City R R R R 80 Addr at DX--State R R R R NAACCR 90 County at DX R R R R R FIPS/ 100 Addr at DX--Postal Code R R R R NAACCR 110 Census Tract 1970/80/90 RH RH RH 120 Census Cod Sys 1970/80/90 RH RH RH 130 Census Tract 2000 R R R 140 Census Tract Cod Sys--Alt NAACCR Retired 150 Marital Status at DX S R R 160 Race 1 R R R R R / 161 Race 2 R R R R R / 162 Race 3 R R R R R / 163 Race 4 R R R R R / 164 Race 5 R R R R R / 170 Race Coding Sys--Current R R NAACCR 180 Race Coding Sys--Original R R NAACCR 190 Spanish/Hispanic Origin R R R R R / 200 Computed Ethnicity S R R NAACCR 210 Computed Ethnicity Source S R R NAACCR 220 Sex R R R R R / 230 Age at Diagnosis R R R R R / 240 Birth Date R R R R R / 250 Birthplace R* R R R R / 260 Religion Varies 270 Occupation Code--Census S Census/NPCR 280 Industry Code--Census S Census/NPCR 290 Occupation Source S NPCR 300 Industry Source S NPCR 310 Text--Usual Occupation R* NPCR 320 Text--Usual Industry R* NPCR 330 Occup/Ind Coding System S NPCR 340 Tobacco History Varies Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
2 350 Alcohol History Varies 360 Family History of Cancer Varies 362 Census Tract Block Group Census 364 Census Tr Cert 1970/80/90 RH RH RH 365 Census Tr Certainty 2000 R R R 370 Reserved Sequence Number--Central R R R NAACCR 390 Date of Diagnosis R R R R R / 400 Primary Site R R R R R / 410 Laterality R R R R R / 419 Morph--Type&Behav ICD-O Histology (92-00) ICD-O-2 RH RH RH RH / 430 Behavior (92-00) ICD-O-2 RH RH RH RH / 440 Grade R R R R R / 450 Site Coding Sys--Current S R R NAACCR 460 Site Coding Sys--Original R R NAACCR 470 Morph Coding Sys--Current S R R NAACCR 480 Morph Coding Sys--Originl R R NAACCR 490 Diagnostic Confirmation R R R R R / 500 Type of Reporting Source R R R 510 Screening Date 520 Screening Result 521 Morph--Type&Behav ICD-O Histologic Type ICD-O-3 R R R R R / 523 Behavior Code ICD-O-3 R R R R R / 530 Reserved Reporting Hospital FAN 540 Reporting Hospital S R R R 550 Accession Number--Hosp S R R R 560 Sequence Number--Hospital S R R R 570 Abstracted By R R R 580 Date of 1st Contact R R R NAACCR 590 Date of Inpatient Adm 600 Date of Inpatient Disch 610 Class of Case S R R RC 620 Year First Seen This CA 630 Primary Payer at DX R R 640 Inpatient/Outpt Status 650 Presentation at CA Conf 660 Date of CA Conference Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
3 670 RX Hosp --Surg Prim Site R R R 672 RX Hosp --Scope Reg LN Sur R R R 674 RX Hosp --Surg Oth Reg/Dis R R R 676 RX Hosp --Reg LN Removed RH Revised 680 Reserved RX Hosp --Radiation RH RH Revised 700 RX Hosp --Chemo R R R 710 RX Hosp --Hormone R R R 720 RX Hosp --BRM R R R 730 RX Hosp --Other R R R 740 RX Hosp --DX/Stg Proc R R 742 RX Hosp --Screen/BX Proc1 743 RX Hosp --Screen/BX Proc2 744 RX Hosp--Screen/BX Proc3 745 RX Hosp --Screen/BX Proc4 746 RX Hosp --Surg Site RH RH Revised 747 RX Hosp --Scope Reg RH RH Revised 748 RX Hosp --Surg Oth RH RH Revised 750 Reserved Summary Stage 2000 RH R R Revised 760 Summary Stage 1977 RH RH RH 770 Loc/Reg/Distant Stage Varies 779 Extent of Disease 10-Dig 780 EOD--Tumor Size RH RH RH / Revised 790 EOD--Extension RH RH Revised 800 EOD--Extension Prost Path RH RH Revised 810 EOD--Lymph Node Involv RH RH Revised 820 Regional Nodes Positive S R R R R / 830 Regional Nodes Examined S R R R R /C0C 840 EOD--Old 13 Digit RH RH 850 EOD--Old 2 Digit RH RH 860 EOD--Old 4 Digit RH RH 870 Coding System for EOD R R 880 TNM Path T R R AJCC 890 TNM Path N R R AJCC 900 TNM Path M R R AJCC 910 TNM Path Stage Group R R AJCC 920 TNM Path Descriptor R R 930 TNM Path Staged By R R 940 TNM Clin T R R AJCC Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
4 950 TNM Clin N R R AJCC 960 TNM Clin M R R AJCC 970 TNM Clin Stage Group R R AJCC 980 TNM Clin Descriptor R R 990 TNM Clin Staged By R R 1000 TNM Other T AJCC 1010 TNM Other N AJCC 1020 TNM Other M AJCC 1030 TNM Other Stage Group AJCC 1040 TNM Other Staged By 1050 TNM Other Descriptor 1060 TNM Edition Number R R 1070 Other Staging System 1080 Date of 1st Positive BX 1090 Site of Distant Met 1 RH 1100 Site of Distant Met 2 RH 1110 Site of Distant Met 3 RH 1120 Pediatric Stage 1130 Pediatric Staging System 1140 Pediatric Staged By 1150 Tumor Marker 1 RH RH RH RH Revised 1160 Tumor Marker 2 RH RH RH RH Revised 1170 Tumor Marker 3 RH RH RH RH Revised 1180 Reserved Reserved RX Date--Surgery S R R 1210 RX Date--Radiation S R R 1220 RX Date--Chemo 1230 RX Date--Hormone 1240 RX Date--BRM 1250 RX Date--Other S R R 1260 Date of Initial RX-- # R R 1270 Date of 1st Crs RX-- # R R 1280 RX Date--DX/Stg Proc R R 1290 RX Summ--Surg Prim Site R R R R R / 1292 RX Summ--Scope Reg LN Sur R R R R R / 1294 RX Summ--Surg Oth Reg/Dis R R R R R / 1296 RX Summ--Reg LN Examined RH RH RH RH / Revised 1300 Reserved RX Summ--Surgical Approch RH Revised Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
5 1320 RX Summ--Surgical Margins R R 1330 RX Summ--Reconstruct 1st RH RH 1340 Reason for No Surgery S R R R R / 1350 RX Summ--DX/Stg Proc R R 1355 Reserved RX Summ--Radiation RH R R Revised 1370 RX Summ--Rad to CNS RH RH / 1380 RX Summ--Surg/Rad Seq S R R R R / 1390 RX Summ--Chemo S R R R R / 1400 RX Summ--Hormone S R R R R / 1410 RX Summ--BRM S R R R R / 1420 RX Summ--Other S R R R R / 1430 Reason for No Radiation S R R 1440 Reason for No Chemo 1450 Reason for No Hormone 1460 RX Coding System--Current R R R RH NAACCR Revised 1470 Protocol Eligibility Stat 1480 Protocol Participation 1490 Referral to Support Serv 1500 First Course Calc Method NAACCR 1510 Rad--Regional Dose: cgy R R 1520 Rad--No of Treatment Vol R R 1530 Rad--Elapsed RX Days 1540 Rad--Treatment Volume R R 1550 Rad--Location of RX R R 1560 Rad--Intent of Treatment 1570 Rad--Regional RX Modality S R R RC 1580 Rad--RX Completion Status 1590 Rad--Local Control Status 1600 Chemotherapy Field 1 Retired 1610 Chemotherapy Field 2 Retired 1620 Chemotherapy Field 3 Retired 1630 Chemotherapy Field 4 Retired 1635 Reserved RX Summ--Surgery Type RH RH 1642 RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Surg Site RH RH RH RH / Revised Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
6 1647 RX Summ--Scope Reg RH RH RH RH / Revised 1648 RX Summ--Surg Oth RH RH RH RH / Revised 1650 Reserved Subsq RX 2nd Course Date 1670 Subsq RX 2nd Course Codes 1671 Subsq RX 2nd Course Surg 1672 Subsq RX 2nd Course Rad 1673 Subsq RX 2nd Course Chemo 1674 Subsq RX 2nd Course Horm 1675 Subsq RX 2nd Course BRM 1676 Subsq RX 2nd Course Oth 1677 Subsq RX 2nd--Scope LN SU 1678 Subsq RX 2nd--Surg Oth 1679 Subsq RX 2nd--Reg LN Rem 1680 Subsq RX 3rd Course Date 1690 Subsq RX 3rd Course Codes 1691 Subsq RX 3rd Course Surg 1692 Subsq RX 3rd Course Rad 1693 Subsq RX 3rd Course Chemo 1694 Subsq RX 3rd Course Horm 1695 Subsq RX 3rd Course BRM 1696 Subsq RX 3rd Course Oth 1697 Subsq RX 3rd--Scope LN Su 1698 Subsq RX 3rd--Surg Oth 1699 Subsq RX 3rd--Reg LN Rem 1700 Subsq RX 4th Course Date 1710 Subsq RX 4th Course Codes 1711 Subsq RX 4th Course Surg 1712 Subsq RX 4th Course Rad 1713 Subsq RX 4th Course Chemo 1714 Subsq RX 4th Course Horm 1715 Subsq RX 4th Course BRM 1716 Subsq RX 4th Course Oth 1717 Subsq RX 4th--Scope LN Su 1718 Subsq RX 4th--Surg Oth 1719 Subsq RX 4th--Reg LN Rem 1720 Subsq RX 5th Course Date NAACCR 1730 Subsq RX 5th Course Codes 1731 Subsq RX 5th Course Surg NAACCR 1732 Subsq RX 5th Course Rad NAACCR Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
7 1733 Subsq RX 5th Co urse Chemo NAACCR 1734 Subsq RX 5th Course Horm NAACCR 1735 Subsq RX 5th Course BRM NAACCR 1736 Subsq RX 5th Course Oth NAACCR 1737 Subsq RX 5th--Scope LN Su NAACCR 1738 Subsq RX 5th--Surg Oth NAACCR 1739 Subsq RX 5th--Reg LN Rem NAACCR 1740 Reserved Subsq RX--Reconstruct Del 1750 Date of Last Contact R R R R R / 1760 Vital Status R R R R R / 1770 Cancer Stat us R R 1780 Quality of Survival 1790 Follow-Up Source R 1800 Next Follow-Up Source R 1810 Addr Current--City R R 1820 Addr Current--State R R NAACCR 1830 Addr Current--Postal Code R R NAACCR 1835 Reserved County--Current 1842 Follow-Up Contact--City R NAACCR 1844 Follow-Up Contact--State R NAACCR 1846 Follow-Up Contact--Postal R NAACCR 1850 Unusual Follow-Up Method 1860 Recurrence Date--1st S R R RC 1871 Recurrence Distant Site Recurrence Distant Site Recurrence Distant Site Recurrence Type--1st S R R RC 1890 Recurrence Type--1st--Oth 1900 Reserved Cause of Death R R R / 1920 ICD Revision Number R R R / 1930 Autopsy 1940 Place of Death S NAACCR 1950 Reserved Site (73-91) ICD-O-1 RH RH RH 1970 Morph (73-91) ICD-O Histology (73-91) ICD-O-1 RH RH RH 1972 Behavior (73-91) ICD-O-1 RH RH RH Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
8 1973 Grade (73-91) ICD-O-1 RH RH RH 1980 ICD-O-2 Conversion Flag R R RH RH 1981 Over-ride SS/NodesPos NAACCR 1982 Over-ride SS/TNM-N NAACCR 1983 Over-ride SS/TNM-M NAACCR 1984 Over-ride SS/DisMet1 NAACCR 1985 Over-ride Acsn/Class/Seq R R NAACCR 1986 Over-ride HospSeq/DxConf R R NAACCR 1987 Over-ride -Site/Type R R NAACCR 1988 Over-ride HospSeq/Site R R NAACCR 1989 Over-ride Site/TNM-StgGrp R R NAACCR 1990 Over-ride Age/Site/Morph R R R R R 2000 Over-ride SeqNo/DxConf R R R 2010 Over-ride Site/Lat/SeqNo S R R 2020 Over-ride Surg/DxConf R R R R R 2030 Over-ride Site/Type R R R R R 2040 Over-ride Histology R R R R R 2050 Over-ride Report Source R R R 2060 Over-ride Ill-define Site R R R 2070 Over-ride Leuk, Lymphoma R R R R R 2071 Over-ride Site/Behavior R R R R R 2072 Over-ride Site/EOD/DX Dt S R R 2073 Over-ride Site/Lat/EOD S R R 2074 Over-ride Site/Lat/Morph R R R R R 2080 Reserved CRC CHECKSUM NAACCR 2090 Date Case Completed Varies 2100 Date Case Last Changed Varies 2110 Date Case Report Exported S R NAACCR 2111 Date Case Report Received R NAACCR 2112 Date Case Report Loaded S NAACCR 2113 Date Tumor Record Availbl S NAACCR 2114 Future Use Timeliness 1 Retired 2115 Future Use Timeliness 2 Retired 2116 ICD-O-3 Conversion Flag R R R R R / 2120 Coding Sys--Current S NAACCR 2130 Coding Sys--Original S NAACCR 2140 Coding Sys--Current S R R 2150 Coding Sys--Original S R R NAACCR 2160 Subsq Report for Primary NAACCR Retired Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
9 2161 Reserved 20 Retired 2170 Vendor Name R NAACCR 2180 Type of Follow-Up R R 2190 Record Number R Revised 2200 Diagnostic Proc RH RH 2210 Reserved 14 Retired 2220 State/Requestor Items Varies 2230 Name--Last R R R NAACCR 2240 Name--First R R R NAACCR 2250 Name--Middle R R R 2260 Name--Prefix 2270 Name--Suffix R 2280 Name--Alias S R 2290 Name--Spouse/Parent Varies 2300 Medical Record Number S R R NAACCR 2310 Military Record No Suffix R 2320 Social Security Number R R R 2330 Addr at DX--No & Street S R R 2335 Addr at DX--Supplementl S R NAACCR 2350 Addr Current--No & Street R R 2352 Latitude NAACCR 2354 Longitude NAACCR 2355 Addr Current--Supplementl R NAACCR 2360 Telephone R R 2370 DC State Retired 2371 Reserved 21 Retired 2380 DC State File Number S State 2390 Name--Maiden S R NAACCR 2392 Follow-Up Contact--No&St R NAACCR 2393 Follow-Up Contact--Suppl NAACCR 2394 Follow-Up Contact--Name R NAACCR 2400 Reserved 16 Retired 2410 Institution Referred From R NAACCR 2420 Institution Referred To R NAACCR 2430 Last Follow-Up Hospital NAACCR 2440 Following Registry R R NAACCR 2450 Reserved 17 Retired 2460 Physician--Managing 2470 Physician--Follow-Up R R 2480 Physician--Primary Surg R Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
10 2490 Physician 3 R 2500 Physician 4 R 2520 Text--DX Proc--PE R^ R NAACCR 2530 Text--DX Proc--X-ray/Scan R^ R NAACCR 2540 Text--DX Proc--Scopes R^ R NAACCR 2550 Text--DX Proc--Lab Tests R^ R NAACCR 2560 Text--DX Proc--Op R^ R NAACCR 2570 Text--DX Proc--Path R^ R NAACCR 2580 Text--Primary Site Title S R NAACCR 2590 Text--Histology Title S R NAACCR 2600 Text--Staging R^ R NAACCR 2610 RX Text--Surgery R^ R NAACCR 2620 RX Text--Radiation (Beam) S R NAACCR 2630 RX Text--Radiation Other S R NAACCR 2640 RX Text--Chemo S R NAACCR 2650 RX Text--Hormone S R NAACCR 2660 RX Text--BRM S R NAACCR 2670 RX Text--Other S R NAACCR 2680 Text--Remarks S R NAACCR 2690 Place of Diagnosis S NAACCR 2700 Reserved CS Tumor Size S R R R R AJCC Revised 2810 CS Extension R R R R R AJCC Revised 2820 CS Tumor Size/Ext Eval S R R AJCC Revised 2830 CS Lymph Nodes R R R R R AJCC Revised 2840 CS Reg Nodes Eval S R R AJCC Revised 2850 CS Mets at DX R R R R R AJCC Revised 2860 CS Mets Eval S R R AJCC Revised 2880 CS Site-Specific Factor 1 RS R R R R AJCC Revised 2890 CS Site-Specific Factor 2 S R R R R AJCC Revised 2900 CS Site-Specific Factor 3 RS R R R R AJCC Revised 2910 CS Site-Specific Factor 4 S R R R R AJCC Revised 2920 CS Site-Specific Factor 5 S R R R R AJCC Revised 2930 CS Site-Specific Factor 6 S R R R R AJCC Revised 2935 CS Version 1st R R R R R AJCC New 2936 CS Version Latest R R R R R AJCC New 2940 Derived AJCC T D R R D D AJCC Revised 2950 Derived AJCC T Descriptor D R R AJCC Revised 2960 Derived AJCC N D R R D D AJCC Revised 2970 Derived AJCC N Descriptor D R R AJCC Revised Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
11 2980 Derived AJCC M D R R D D AJCC Revised 2990 Derived AJCC M Descriptor D R R AJCC Revised 3000 Derived AJCC Stage Group D R R D D AJCC Revised 3010 Derived SS1977 D R R D D AJCC Revised 3020 Derived SS2000 D R R D D AJCC Revised 3030 Derived AJCC--Flag D R R D D AJCC Revised 3040 Derived SS1977--Flag D R R D D AJCC Revised 3050 Derived SS2000--Flag D R R D D AJCC Revised 3100 Archive FIN R R 3110 Comorbid/Complication 1 R R 3120 Comorbid/Complication 2 R R 3130 Comorbid/Complication 3 R R 3140 Comorbid/Complication 4 R R 3150 Comorbid/Complication 5 R R 3160 Comorbid/Complication 6 R R 3170 RX Date--Most Defin Surg S R R 3180 RX Date--Surgical Disch R R 3190 Readm Same Hosp 30 Days R R 3200 Rad--Boost RX Modality R R RC 3210 Rad--Boost Dose cgy R R 3220 RX Date--Radiation Ended R R 3230 RX Date--Systemic S R R 3250 RX Summ--Transplnt/Endocr S R R R R 3260 Pain Assessment Retired 3270 RX Summ--Palliative Proc R R 3280 RX Hosp --Palliative Proc R R 3300 RuralUrban Continuum 1993 D NAACCR Revised 3310 RuralUrban Continuum 2000 D NAACCR Revised Codes for Recommendations: R = Required. RH = Historically collected and currently transmitted. RC = ed by from * = When available. # = Central registries may code available data using either or data item and associated rules. ^ = These text
ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry
ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data Item Name Data Item Number NPCR Collect Recommendation
APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13)
APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13) New Required Item by ASCR R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data NPCR Collect
Pathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative
GATRA 2016 Breast Case Demographics Name: Autumn Leaf Sex: F Date of Birth: 3/26/75 SSN: 098765432 Race: African American Marital Status: Single Address: 3615 Burnt Hickory Trail, Helen, GA 37285, White
2010 Cancer Data Collection Updates: Standards Volume II, Introduction. What s New for 2010
2010 Cancer Data Collection Updates: Standards Volume II, Version 12 NAACCR 2009 2010 Webinar Series Introduction What s New for 2010 Record length and record layout New/changed data items Multiple Primary
1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ Primary Site (291) = C711 Date of Diagnosis (283) =
Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This
1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) =
Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This
The Components of an Abstract. Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018
The Components of an Abstract Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018 1 Abstracts Should Tell A Story 2 The Components of an Abstract Who
Requirements for Abstracted Text
Slide 1 Requirements for Abstracted Text Principles of Abstracting Lesson 3: Purpose of Text Slide 2 Available Text Fields Place of Diagnosis Immunotherapy Chemotherapy Hormone Therapy Other Therapy Radiation
I.2 CNExT This section was software specific and deleted in 2008.
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I Changes and Clarifications 8th th Edition Revised May 2008 SECTION
NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions
NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume
QUICK-START GUIDE NCDB Participant Use File (NCDB PUF)
QUICK-START GUIDE 2015 NCDB Participant Use File (NCDB PUF) The data included in this zipped file are provided in a flat text file format, and should be read with software such as SAS, SPSS (PASW), STATA,
Alternate Name Item # Length Source of Standard Column # Alternate Name Item # Length Source of Standard Column #
RESERVED 04 750 46 482-527 RESERVED 05 1180 50 705-754 RESERVED 06 1190 45 943-987 RESERVED 07 1300 50 1065-1114 RESERVED 08 1650 50 1244-1293 RESERVED 09 1740 50 1397-1446 RESERVED 10 1835 50 2415-2464
ON-LINE REGISTRATION FCDS MONOGRAPH: 2004 ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FLORIDA ANNUAL CANCER REPORT: 2001 INCIDENCE
ON-LINE REGISTRATION FOR THE FCDS ANNUAL CONFERENCE, JULY 27-28, 2006, AND BROCHURE FCDS 2006 IMPLEMENTATION GUIDE FOR NAACCR VERSION 11 (REVISED 5/22/2006; ADDS NEW AND UPDATED EDITS FOR CASES RECEIVED
FORDS. Facility Oncology Registry Data Standards Revised for 2010 (Incorporates all updates since originally published in July 2002)
FORDS Facility Oncology Registry Data Standards Revised for 2010 (Incorporates all updates since originally published in July 2002) Includes updates to May 1, 2010 See Appendix C for a summary of changes.
Abstract Code Manual
16th Edition Abstract Code Manual MISSOURI CANCER REGISTRY AND RESEARCH CENTER University of Missouri Columbia 2016 Revised Missouri Cancer Registry and Research Center Abstract Code Manual 16th Edition
FCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data
FCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data 2011 FCDS Educational Webcast Series Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR August 18, 2011 CDC-NPCR
CCARM. Cancer Collection and Reporting Manual Revised for 2016
This publication was supported by cooperative agreement N.C. U55CCU421885 awarded to the from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and
Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1
Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1
CERVIX MEASURE SPECIFICATIONS
Cancer Programs Practice Profile Reports (CP 3 R) CERVIX MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve
Setting the stage for change: upgrading the physician cancer case reporting application in New York
Setting the stage for change: upgrading the physician cancer case reporting application in New York April Austin New York State Cancer Registry (NYSCR) July 12, 2018 June 13, 2018 Aerial view of Thousand
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I
CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I SUMMARY OF YEAR 2004 DATA CHANGES This document will provide a summary
2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018?
2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018? SESSION 2 10/20/17 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session, the Q&A,
Abstracting and Coding Boot Camp: Cancer Case Scenarios
NAACC R 2015-2016 Webinar Series Abstracting and Coding Boot Camp: Cancer Case Scenarios NAACCR 2015 2016 Webinar Series Presented by: Angela Martin amartin@naaccr.org Jim Hofferkamp jhofferkamp@naaccr.org
Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.
Q&A Breast Webinar Q: One of my investigators is interested in knowing when Oncotype DX data collection was implemented. That data is collected in SSFs 22 and 23. I remember that the SSFs for breast were
Part VIII Entering Information Into the Urology Report Form
North Carolina Central Cancer Registry Instructions and Reporting Requirements Module 8 Electronic Reporting For Urology Physician Practices May 2013 North Carolina Central Cancer Registry State Center
Michigan Cancer Surveillance Program
Michigan Cancer Surveillance Program Supplemental Guidance for the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, HL7 Clinical Document Architecture (CDA)
North American Association of Central Cancer Registries, Inc. (NAACCR)
North American Association of Central Cancer Registries, Inc. (NAACCR) 2015 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 15,
Prostate Case Scenario 1
Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has
North American Association of Central Cancer Registries, Inc. (NAACCR)
North American Association of Central Cancer Registries, Inc. (NAACCR) 2016 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 16,
1 : Patient Details. 2 : Medical Aid Details. 3 : Practitioner Detail (Practice) 4 : Patient History
1 : Patient Details Surname: Firstname: Initials: ID Number: First Diagnosed: Gender: Telephone: CellPhone: Dependant Code: Birth: Postal Address Fax: Email: 2 : Medical Aid Details Principal Member: Membership
7/29/2014. Patterns of Care in Colon Cancer ( ) Literature. Background. Florida Cancer Data Compliance with NCCN Guidelines
Patterns of Care in Colon Cancer (21-212) Florida Cancer Data Compliance with FCDS Annual Meeting July 24-25, 214 Caribe Royale Resort Orlando, Florida Background O NCCN guidelines are referenced extensively
Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry
Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry April 2015 2015 Data Changes New Data Items Revised Data Items ICD-0-3 Reportability Change New ICDO Terms and Codes SEER
2018 New Required Data Items for Hospitals
2018 New Required Data Items for Hospitals The NJSCR is a population-based registry, mandated by state law, that collects data on all cancer cases diagnosed and/or treated in New Jersey since October 1,
Standards for Cancer Registries, Volume I. Data Exchange Standards and Record Descriptions
Standards for Cancer Registries, Volume I Data Exchange Standards and Record Descriptions Version 18 March 2018 Edited by Lori A. Havener, CTR Program Manager of Standards North American Association of
10/24/2013. Continuing Education Hours. Presentation Outline. Rule Makers for National Data Collection. NPCR Program Standards,
2 013-2014 QUALITY IMPROVEMENT EDUCATION AND TRAINING NCRA CEU # 2013-114 Continuing Education Hours Date Event Sponsor 7/25/2013-7/26/2013 CEU Hrs FCDS Annual Conference, Sunrise, FL FCDS 8.25 2013-115
Canadian Cancer Registry Reference Guide For Years
Canadian Cancer Registry Reference Guide For Years 2000-2015 Compiled by: Edna Kalu, Zikuan Liu HOW TO OBTAIN MORE INFORMATION For more information about this guide or other services and data available
MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR
MCR: MANAGEMENT OF 2018 CHANGES By: Maricarmen Traverso-Ortiz MPH, CGG, CTR LEARNING OBJECTIVES Discuss a summary of the new changes for 2018 Overview of how the Maryland Cancer Registry is managing and
NPCR CLINICAL EDIT CHECKS
NPCR CLINICAL EDIT CHECKS FCDS Annual Meeting July 26, 2013 Sunrise, Flrida Steven Peace, CTR FCDS Data Quality Staff PURPOSE OF CLINICAL EDIT CHECKS The primary purpse f the Clinical Check edits is t
Cancer as a Disease. Linda D. Rego, CTR March 2009
Cancer as a Disease Linda D. Rego, CTR March 2009 Historic perspective First records date as early as 2500 B.C. In Egypt recorded on papyrus Outlines pharmacological, mechanical and magical treatments
AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?
AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? FCRA Annual Conference Boca Raton, Florida 7/26/2016 Steven Peace, CTR 1 Introduction Order AJCC Cancer Staging Manual, 7 th ed. How To Use - AJCC Cancer
Cancer Registry Abstracting FLORIDA CANCER DATA SYSTEM
Cancer Registry 1 Learning Objectives 2 Integrate previously learned principles of cancer identification (anatomy, casefinding, site and histology identification principles, staging principles, and treatment
Stage Data Capture in Ontario
Stage Data Capture in Ontario February 23, 2010 Agenda Refresher: Ontario s Stage Capture Project Collaborative Staging and Population Stage Reporting in Ontario Use of Stage Data in System Performance
Lesson 8 Classifications
Lesson 8 Classifications Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers for Disease
Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of alcohol.
2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights
F l o r i d a S t a t e w i d e C a n c e r R e g i s t r y 2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights 2014-2015 FCDS Webcast Series Steven Peace, CTR August 21, 2014 2014 FCDS Annual
Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors
CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior
Cancer Data Uses and Dissemination. State of the State Florida Cancer Data System /21/2014. Certification. Presentation Outline
F l o r i d a S t a t e w i d e C a n c e r R e g i s t r y 2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights 2014 FCDS Annual Conference Recordings & Handouts http://fcds.med.miami.edu/inc/educationtraining.shtml
Collecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009
Collecting Cancer Data: Prostate NAACCR 2008-2009 Webinar Series June 11, 2009 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview 2008-2009 NAACCR Webinar Series
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed
VISUAL EDITING GUIDELINES March 2015 (revised June 2015)
March 2015 (revised June 2015) Developed for The Cancer Registry of Greater California under the direction of Winny Roshala, BA, CTR, Data Quality Control Director By the following contributing Authors:
Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.
Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of
Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.
Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This
Interactive Discussion of Part I CS Coding Instructions: Working the Cases
Interactive Discussion of Part I CS Coding Instructions: Working the Cases April Fritz, RHIT, CTR Donna M. Gress, RHIT, CTR Jennifer Ruhl, RHIT, CCS, CTR This presentation was supported by the Cooperative
The Death Clearance Process: What Do We Gain From Our Efforts?
The Death Clearance Process: What Do We Gain From Our Efforts? Colleen G. Sherman Maria J. Schymura April A. Austin Baozhen Qiao NAACCR 2012 Objectives Demonstrate the variability of resolution from follow
FCDS TENTATIVE V11 TO V11.1 IMPLEMENTATION SCHEDULE
NAACCR V11.1 UPDATES ZIP CODE, FIPS COUNTY, FLORIDA CITY NAME VERIFICATION FILE (COMMA SEPARATED TEXT FILE) CANCER TRAINING: PRINCIPLES AND PRACTICE OF CANCER REGISTRATION, SURVEILLANCE AND CONTROL, JULY
Newton Wellesley Hospital 2013
Newton Wellesley Hospital 20 Standard 4.6 Assessment and Evaluation of Treatment Planning Endometrial Cancer Each year a physician member of the cancer committee conducts a study to ensure that diagnostic
North American Association of Central Cancer Registries, Inc. (NAACCR)
North American Association of Central Cancer Registries, Inc. (NAACCR) 2018 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 18,
NPCR s TNM Stage Calculator
NPCR s TNM Stage Calculator A Tool for Central Registry Quality Control and Consolidation Assistance NAACCR Annual Meeting June 16, 2016 Jennifer Seiffert Northrop Grumman Under contract to NPCR Joseph
4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines
SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific
American College of Surgeons 2014 Content cannot be reproduced or repurposed without written permission of the American College of Surgeons.
Revision of the FORDS Manual: A Process Dependent on Registrar and Clinician Input Frederick L. Greene, MD FACS Medical Director, Cancer Data Services, Levine Cancer Institute, Charlotte, NC 1 2 Disease
Florida Cancer Data System STAT File Documentation Version 2019
Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status
12/10/2012 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS. Continuing Education Hours. Presentation Outline
IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS FCDS Webcast Series Steven Peace, BS, CTR December 13, 2012 2 Continuing Education Hours NCRA CEU # 2012-065 Date(s)
12/10/2012. Continuing Education Hours IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS
2 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS NCRA CEU # 2012-065 Continuing Education Hours Date(s) Event 7/26/2012-7/27/2012 2012-155 8/16/2012 Spons or FCDS
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.
Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity. Background: 46 year old married premenopausal female with dense breasts has noticed
EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013
EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH
AJCC TNM 6 th Edition Staging Input Data Dictionary
Catalogue no. 82-225-XIE No. 001 ISSN: 1715-2100 O ISBN: 0-662-41801-8 Manuals AJCC TNM 6 th Edition Staging Input Data Dictionary by Michel Cormier Health Statistics Division Client Custom Services Room
Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.
Case Scenario 1 3/8/13 H&P 68 YR W/M presents w/elevated PSA. Patient is a non-smoker, current alcohol use. Physical Exam: On digital rectal exam the sphincter tone is normal and there is a 1 cm nodule
The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process
The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process Wednesday, April 29, 2009 at 11 AM Central M. Asa Carter, CTR Manager, Approvals and Standards
NAACR Treatment Webinar Quiz 1
NAACR Treatment Webinar Quiz 1 1. Which of the following would NOT be considered cancer-directed treatment? a. Hemicolectomy b. Incisional biopsy c. Whole breast radiation d. MRI e. All of the above f.
CINA Deluxe Data Quality Profile
CINA Deluxe Data Quality Profile Date DQP produced: February 9, 2018 Variable examined: CS Site-Specific Factor 1 (SSF1): Estrogen Receptor (ER) (NAACCR Data Item #: 2880) CS Site-Specific Factor 2 (SSF2):
Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast
Collecting Cancer Data Breast NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)
O COLON MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff
Pancreas Case Scenario #1
Pancreas Case Scenario #1 An 85 year old white female presented to her primary care physician with increasing abdominal pain. On 8/19 she had a CT scan of the abdomen and pelvis. This showed a 4.6 cm mass
Who What When Where Why. Case Finding 5 W s. NAACCR Webinar Series. Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC
Who What When Where Why Case Finding 5 W s NAACCR 2010-2011 Webinar Series Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC Agenda Case Finding Purpose Reportable lists Benign intracranial
Commission on Cancer Updates
Commission on Cancer Updates OBJECTIVES PROVIDE CANCER REGISTRARS WITH INFORMATION ABOUT CURRENT COC 2018 CHANGES DISCUSS CHANGES RELATED TO CANCER REGISTRY DATA COLLECTION DISCUSS CHANGES RELATED TO CANCER
The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study
The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study Robert R. German, DrPH, MPH; Tim Byers, MD, MPH; Holly Wolf, PhD, MSPH; Jen Wike, MBA, MPH; Linda Alley,
Case Scenario 1 History and Physical 3/15/13 Imaging Pathology
Case Scenario 1 History and Physical 3/15/13 The patient is an 84 year old white female who presented with an abnormal mammogram. The patient has a five year history of refractory anemia with ringed sideroblasts
Collecting Cancer Data: Pancreas
Collecting Cancer Data: Pancreas NAACCR 2011 2012 Webinar Series 1/5/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this
Utilization of OncoType DX Test for
Utilization of OncoType DX Test for Breast Cancer in the Community Setting XC Wu, XR Li, V Petkov, MC Hsieh, M Loch, PA Andrews, VW Chen 2016 NAACCR Annual Conference June 8, 2016 Background Chemotherapy
NAACCR Webinar 2018 SeriesImplementations and Timelines
NAACCR 2015-2016 Webinar 2018 SeriesImplementations and Timelines August 8, 2017 Session 1 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session,
The Impact of E-Path Technology on the Ontario Cancer Registry. Operations
The Impact of E-Path Technology on the Ontario Cancer Registry Pathology LIS Operations Presented at the NAACCR 2002 Cancer Informatics Workshop Toronto, Ontario June 2002 EDI Darlene Dale Manager, Ontario
ARDS. of the Commission on Cancer. Volume II: Registry Operations and Data Standards (ROADS) Revised 1/1/98
STAND ANDARDS ARDS of the Commission on Cancer Volume II: Registry Operations and Data Standards (ROADS) Revised 1/1/98 1998 Commission on Cancer, American College of Surgeons Commission on Cancer 633
General Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators
American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without written permission of of the the American College College of Surgeons. of Surgeons.
Informational Abstracts: A Guide to Quality Abstracting
Informational Abstracts: A Guide to Quality Abstracting Presented by NCRA Education Committee Carole Eberle, BS, CTR Louise Schuman, MA, CTR NCRA Education Committee NCRA Strategic Planning and Education
FORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute
FORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute Charlotte, NC National Accreditation Program for Breast
Registrar s Guide to Chapter 1, AJCC Seventh Edition. Overview. Learning Objectives. Describe intent and purpose of AJCC staging
Registrar s Guide to Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers for Disease Control
SECTION II: GENERAL ABSTRACTING INSTRUCTIONS
SECTION II: GENERAL ABSTRACTING INSTRUCTIONS 60 SECTION II: GENERAL ABSTRACTING INSTRUCTIONS It is the responsibility of every abstractor to know the content of the FCDS Data Acquisition Manual (DAM) and
AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by
AJCC 8 th Edition Staging Introduction & Descriptors Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving
5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry
AJCC Stage Introduction and General Rules Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]
![Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]](/thumbs/82/86783199.jpg "Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ]")
CS Tumor Size Collaborative Stage for TNM 7 - Revised 12/02/2009 [ Schema ] Note: the specific tumor size as documented in the medical record. If the ONLY information regarding tumor size is the physician's
ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *
ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:
CS Tumor Size. We re on the Web! Visit us at www2.kumc.edu/kcr
VOLUME 17 ISSUE 3 July 2013 We re on the Web! Visit us at www2.kumc.edu/kcr July is UV Awareness Month. It is that time of the year again for summer! This is a great opportunity to talk about skin cancer.
1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.
History and Physical Case Scenario 1 45 year old white male presents with complaints of nausea, weight loss, and back pain. A CT of the chest, abdomen and pelvis was done on 12/8/12 that revealed a 12
Evaluation of Cancer Outcomes Barwon South West Registry
Evaluation of Cancer Outcomes Barwon South West Registry Data Request Form Applicant details Applicant name: Position: Email: Project start date: Date: Telephone: Project completion date: Project details
Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma
Case Scenario 1 History A 52 year old male with a 20 pack year smoking history presented with about a 6 month history of persistent hoarseness. The patient had a squamous cell carcinoma of the lip removed
This section allows identifying the facility, this information is important for data quality follow up. Source of Standard. Source of Standard
Data Dictionary Case Administration This section allows identifying the facility, this information is important for data quality follow up Facility Name This identifier is needed to evaluate This data
Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.
Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to
Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)
MEASURE SPECIFICATIOS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) ational Cancer Data Base (CDB) staff has undertaken
North American Association of Central Cancer Registries, Inc. (NAACCR)
North American Association of Central Cancer Registries, Inc. (NAACCR) Death Clearance Manual Minimum Requirements and Best Practices for Conducting Death Clearance Effective January 1, 2015 for Deaths